When gastrointestinal tumors are mentioned, many people's first reaction is "colonoscopy is too painful," while others think "if I don't feel unwell, I don't need to get checked." However, data from the National Cancer Center shatters this illusion: 70% of gastrointestinal tumor patients are diagnosed at an advanced stage, missing the optimal treatment window. This not only doubles the difficulty of treatment but also significantly reduces the prognosis.
Is gastrointestinal tumor really unpreventable? Absolutely not! Early detection, early diagnosis, and early treatment are the only core secrets to combating gastrointestinal tumors, and age 40 is a critical watershed for digestive health. Traditional early screening methods have low acceptance and strong resistance, becoming the biggest "hidden gap" in early screening. Gut microbiota gene testing is a new way to fill this gap, making early gastrointestinal screening simple, painless, and sustainable for everyone.

I. Why must people over 40 years old prioritize this test?
Medical data has long clearly shown that the risk of developing gastrointestinal tumors is strongly correlated with age. 40 years old is a critical health watershed; missing this stage will lead to a sharp increase in risk, and this should not be taken lightly.
01. Age Triggers High Risk; Early Screening Saves Time
After age 40, the incidence of stomach cancer begins to rise rapidly, and after age 45, the risk of colorectal cancer doubles. Gut microbiota imbalance is a major contributing factor to intestinal polyps, enteritis, and even cancer. Traditional examinations require intubation and appointments, leading many to postpone them. Gut microbiota gene testing, however, requires no intubation, no anesthesia, and is non-invasive and painless. It only requires a stool sample to accurately decode the composition of the gut microbiota, detecting precancerous lesions 3-5 years in advance and nipping the risk in the bud.
02. Screening for High-Risk Groups: More Precise Than Routine Checkups
If you have a history of long-term smoking and excessive alcohol consumption, a preference for high-salt and pickled foods, overeating, insufficient dietary fiber intake, or a family history of digestive tract tumors, you belong to a clearly high-risk group. The proportion of harmful and pathogenic bacteria in your intestines will be much higher than that of ordinary people. This test can accurately identify carcinogenic bacteria such as Fusobacterium nucleatum and Helicobacter pylori, as well as carcinogenic metabolites such as nitrites. It is more targeted than the general examination of ordinary physical examinations, leaving no subtle risks unchecked.
03. Overcoming Resistance to Early Screening: Suitable for Long-Term Regular Screening
Many people resist early screening for the digestive tract, mainly because they are afraid of the invasive procedures of gastroscopy and colonoscopy, worry about the risks of anesthesia and the discomfort of biopsy, and would rather endure the pain than have the test.
Gut microbiota gene testing is entirely non-invasive, causing no physical burden, and can be a routine annual early screening program for people over 40. It is especially suitable for those who fear gastroscopy and colonoscopy or cannot adhere to regular checkups, allowing for easy early screening without the need for wishful thinking.

II. What exactly does in-depth gut microbiota gene testing help us detect?
Many people find genetic testing mysterious, but its results are actually clear and practical, covering three core dimensions to comprehensively protect digestive health:
1. Precise Early Warning of Tumor Risk: Targeted testing of gut microbiota gene markers highly correlated with colorectal and gastric cancer scientifically quantifies cancer risk levels, categorized into low, medium, and high, providing a clear understanding of one's risk profile and preventing unfounded concerns.
2. Comprehensive Diagnosis of Gut Microbiota Imbalance: Detailed analysis of the balance between beneficial bacteria such as Bifidobacteria and Lactobacilli and various harmful bacteria accurately determines the presence of potential lesions such as chronic enteritis and intestinal polyps, identifying the root cause of intestinal discomfort.
3. Personalized Health Intervention Plans: Unlike routine checkups that only provide reports without follow-up, professional testing includes personalized health guidance. Based on individual gut microbiota reports, customized plans are offered, such as dietary adjustments, probiotic supplementation, and lifestyle optimization, to fundamentally regulate the balance of gut microbiota and reduce the risk of cancer from the source.

III. These 5 types of people should prioritize testing; don't wait until symptoms appear to regret it.
✅ People aged 40 and above, regardless of whether they have gastrointestinal discomfort, should undergo early gastrointestinal screening.
✅ People with a direct family history of stomach or colorectal cancer, belonging to the high-risk genetic group.
✅ People who smoke and drink alcohol for a long time, have a high-oil and high-salt diet, and insufficient dietary fiber intake.
✅ People with recurrent diarrhea, constipation, abdominal bloating and pain, or black stools, or unexplained sudden weight loss.
✅ People who fear gastroscopy and colonoscopy, refuse invasive procedures, and resist traditional early screening
IV. Debunk 3 Common Misconceptions and Avoid Wasting Money on Health Testing
Many people have misconceptions about gut microbiota gene testing, and some even miss out on early screening because of these misconceptions. These three common misconceptions must be clarified:
❌ Misconception 1: A positive test means cancer?
✅ Truth:A high-risk result ≠ a confirmed cancer diagnosis. It only indicates a gut microbiota imbalance and a potential risk of precancerous lesions, essentially a "warning signal" from your body. At this time, timely adjustments to diet, improvements in lifestyle, or regular checkups can reduce the probability of cancer by more than 90%, which is precisely the significance of early screening.
❌ Myth 2: Non-invasive testing is less accurate than gastroscopy and colonoscopy, and is useless?
✅ Truth: Gastroscopy and colonoscopy are the "gold standard" for diagnosing digestive tract tumors, mainly used for confirming lesions; while gut microbiota gene testing is a powerful tool for early screening and warning. The two are complementary, not substitutes. Using non-invasive gene testing for preliminary screening, and then performing targeted gastroscopy and colonoscopy for confirmation after identifying high-risk cases, reduces unnecessary examination pain and improves screening efficiency and accuracy.
❌ Myth 3: Only a report after testing, no follow-up guidance?
✅ Truth: Reputable and professional testing services are accompanied by a team of professional physicians and nutritionists. After receiving the report, they will provide one-on-one interpretation, give personalized intervention plans for risk points, and follow up on the improvement of gut health throughout the process. It's not just about finishing the test, but about protecting your gut health throughout the entire process.
Early screening is not a burden, but a responsibility to yourself and your family.

Gastrointestinal tumors may seem frightening, but by focusing on early screening, early detection, early treatment, and even complete prevention of cancer development can be achieved. The "early detection, early treatment" concept consistently advocated by the Lecheng Pilot Zone aims to help the public stay away from serious illnesses and safeguard their health. After 40, don't be afraid of checkups, and don't take chances. Compared to the huge medical bills and physical pain of illness, a simple, non-invasive gut microbiota gene test can bring you 3-5 years of peace of mind regarding your gut health. This is the most responsible choice for yourself and the best protection for your family.





